Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TNF-α Blockade in Psoriatic Arthritis
NCT00432406Phase 4Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- May 2006
- Primary completion
- Mar 2009
- Modality
- Monoclonal Antibodies, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab, etanercept in psoriatic arthritis (PsA), sponsored by The Chinese University of Hong Kong. Started May 2006; status: completed.
02
Drugs
infliximabetanercept
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT00432406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00432406.